Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
02.08.24
/
50%
€46.20
Target price
02.08.25
€68.71
Performance (%)
-46.75%
End price
03.08.25
€24.60
Summary
This prediction ended on 03.08.25 with a price of €24.60. The BUY prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc. performed very badly with a performance of -46.75%. Wells_Fargo___Compan has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 16.667% | 16.667% | -51.000% |
| iShares Core DAX® | 1.822% | 3.926% | 23.507% |
| iShares Nasdaq 100 | 1.093% | -0.585% | 6.034% |
| iShares Nikkei 225® | 3.042% | 1.335% | 17.437% |
| iShares S&P 500 | 1.247% | 0.836% | 4.374% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Wells Fargo & Company from $72.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€26.00
10.07.25
10.07.25
€55.35
10.07.26
10.07.26
-20.00%
07:46
07:46
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€38.21
30.12.26
30.12.26
22.35%
07:46
07:46
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€29.20
20.10.25
20.10.25
€55.74
20.10.26
20.10.26
-28.77%
07:46
07:46
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.80
20.12.24
20.12.24
€84.54
20.12.25
20.12.25
-32.06%
21.12.25
21.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24